{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:56:01Z","timestamp":1792432561113,"version":"4.5.0"},"reference-count":117,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Although various treatment options are available for prostate cancer (PCa), including androgen deprivation therapy (ADT) and chemotherapy, these approaches have not achieved the desired results clinically, especially in the treatment of advanced chemotherapy-resistant PCa. The PI3K\/AKT\/mTOR (PAM) signaling pathway is a classical pathway that is aberrantly activated in cancer cells and promotes the tumorigenesis, metastasis, resistance to castration therapy, chemoresistance, and recurrence of PCa. Noncoding RNAs (ncRNAs) are a class of RNAs that do not encode proteins. However, some ncRNAs have recently been shown to be differentially expressed in tumor tissues compared with noncancerous tissues and play important roles at the transcription and posttranscription levels. Among the types of ncRNAs, long noncoding RNAs (lncRNAs), microRNAs (miRNAs), circular RNAs (circRNAs), and Piwi-interacting RNAs (piRNAs) can participate in the PAM pathway to regulate PCa growth, metastasis, angiogenesis, and tumor stemness. Therefore, ncRNA therapy that targets the PAM signaling pathway is expected to be a novel and effective approach for treating PCa. In this paper, we summarize the types of ncRNAs that are associated with the PAM pathway in PCa cells as well as the functions and clinical roles of these ncRNAs in PCa. We hope to provide novel and effective strategies for the clinical diagnosis and treatment of PCa.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1525741","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T07:03:24Z","timestamp":1742281404000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Exploring the roles of ncRNAs in prostate cancer via the PI3K\/AKT\/mTOR signaling pathway"],"prefix":"10.3389","volume":"16","author":[{"given":"Rongwang","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liji","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-051517-011947","article-title":"Treatment of advanced prostate cancer","volume":"70","author":"Teo","year":"2019","journal-title":"Annu Rev Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"22138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduction Targeting Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-14-0833","article-title":"The selective PI3K inhibitor XL147 (SAR245408) inhibits tumor growth and survival and potentiates the activity of chemotherapeutic agents in preclinical tumor models","volume":"14","author":"Foster","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.10.017","article-title":"The role of non-coding RNAs in oncology","volume":"179","author":"Slack","year":"2019","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2018.01.012","article-title":"Prostate cancer-associated lncRNAs","volume":"418","author":"Mitobe","year":"2018","journal-title":"Cancer Lett"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)71113-1","article-title":"Nomination and validation of the long noncoding RNA SChLAP1 as a risk factor for metastatic prostate cancer progression: A multi-institutional high-throughput analysis","volume":"15","author":"Prensner","year":"2014","journal-title":"Lancet Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1667\/RR14185.1","article-title":"MicroRNA-145 modulates tumor sensitivity to radiation in prostate cancer","volume":"184","author":"Gong","year":"2015","journal-title":"Radiat Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"41214","DOI":"10.1186\/s13046-022-02406-1","article-title":"Molecular landscape of lncRNAs in prostate cancer: A focus on pathways and therapeutic targets for intervention","volume":"41","author":"Mirzaei","year":"2022","journal-title":"J Exp Clin Cancer Res CR"},{"key":"B11","doi-asserted-by":"publisher","first-page":"20239207148","DOI":"10.1155\/2023\/9207148","article-title":"LINC01088\/miR-22\/CDC6 axis regulates prostate cancer progression by activating the PI3K\/AKT pathway","volume":"2023","author":"Li","year":"2023","journal-title":"Mediators Inflammation"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/tox.23656","article-title":"LncRNA RHPN1-AS1 Inhibition Induces Autophagy and Apoptosis in Prostate Cancer Cells via the miR-7-5p\/EGFR\/PI3K\/AKT\/mTOR Signaling Pathway","volume":"37","author":"Ma","year":"2022","journal-title":"Environ Toxicol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3344","article-title":"Long Non-Coding DANCR Targets miR-185-5p to Upregulate LIM and SH3 Protein 1 Promoting Prostate Cancer via the FAK\/PI3K\/AKT\/GSK3\u03b2\/Snail Pathway","volume":"23","author":"Sun","year":"2021","journal-title":"J Gene Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1890383","article-title":"Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN\/PI3K\/AKT\/mTOR signaling","volume":"12","author":"Ding","year":"2021","journal-title":"Bioengineered"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2019.3123","article-title":"Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K\/AKT\/mTOR Signaling by miR-342-3p\/CUL4B Axis in Prostate Cancer","volume":"35","author":"Ma","year":"2020","journal-title":"Cancer Biother Radiopharm"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.11194","article-title":"lncRNA HCG11 regulates cell progression by targeting miR-543 and regulating AKT\/mTOR pathway in prostate cancer","volume":"43","author":"Wang","year":"2019","journal-title":"Cell Biol Int"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27561","article-title":"Mutations in GAS5 affect the transformation from benign prostate proliferation to aggressive prostate cancer by affecting the transcription efficiency of GAS5","volume":"234","author":"Zhu","year":"2019","journal-title":"J Cell Physiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3892\/ol.2022.13401","article-title":"Long non-coding RNA SNHG3 promotes prostate cancer progression by sponging microRNA-1827","volume":"24","author":"Hu","year":"2022","journal-title":"Oncol Lett"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.552907","article-title":"Long non-coding RNA SNHG1 regulates the wnt\/\u03b2-catenin and PI3K\/AKT\/mTOR signaling pathways via EZH2 to affect the proliferation, apoptosis, and autophagy of prostate cancer cell","volume":"10","author":"Chen","year":"2020","journal-title":"Front Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2019.3177","article-title":"Long noncoding RNA SNHG1 contributes to the promotion of prostate cancer cells through regulating miR-377-3p\/AKT2 axis","volume":"35","author":"Xie","year":"2020","journal-title":"Cancer Biother Radiopharm"},{"key":"B21","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s41391-021-00353-0","article-title":"CASC11 Promotes Aggressiveness of Prostate Cancer Cells through miR-145\/IGF1R Axis","volume":"24","author":"Capik","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1515\/hsz-2018-0380","article-title":"Long Non-Coding RNA CHRF Promotes Proliferation and Mesenchymal Transition (EMT) in Prostate Cancer Cell Line PC3 Requiring up-Regulating microRNA-10b","volume":"400","author":"Liu","year":"2019","journal-title":"Biol Chem"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2014.2363","article-title":"Linc00963: A novel, long non-coding RNA involved in the transition of prostate cancer from androgen-dependence to androgen-independence","volume":"44","author":"Wang","year":"2014","journal-title":"Int J Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz108","article-title":"LncRNA PCAT1 activates AKT and NF-\u03baB signaling in castration-resistant prostate cancer by regulating the PHLPP\/FKBP51\/IKK\u03b1 Complex","volume":"47","author":"Shang","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2017.12.005","article-title":"Oncogenic Non-Coding RNA NEAT1 promotes the prostate cancer cell growth through the SRC3\/IGF1R\/AKT pathway","volume":"94","author":"Xiong","year":"2018","journal-title":"Int J Biochem Cell Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"319636897221122997","DOI":"10.1177\/09636897221122997","article-title":"METTL3-Mediated m6A Modification of lncRNA MALAT1 Facilitates Prostate Cancer Growth by Activation of PI3K\/AKT Signaling","volume":"31","author":"Mao","year":"2022","journal-title":"Cell Transplant"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S241093","article-title":"Quercetin Inhibits Epithelial-to-Mesenchymal Transition (EMT) Process and Promotes Apoptosis in Prostate Cancer via Downregulating lncRNA MALAT1","volume":"12","author":"Lu","year":"2020","journal-title":"Cancer Manage Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201907_18420","article-title":"Downregulated LINC00460 inhibits cell proliferation and promotes cell apoptosis in prostate cancer","volume":"23","author":"Dong","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113686","article-title":"Analyzing roles of small nucleolar RNA host gene 25 from clinical, molecular target and tumor formation in prostate cancer","volume":"429","author":"Liu","year":"2023","journal-title":"Exp Cell Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3892\/or.2016.4791","article-title":"Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma","volume":"36","author":"Xu","year":"2016","journal-title":"Oncol Rep"},{"key":"B31","unstructured":"LncRNA PlncRNA-1 accelerates the progression of prostate cancer by regulating PTEN\/Akt axis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S129928","article-title":"Long noncoding RNA LINC01296 is associated with poor prognosis in prostate cancer and promotes cancer-cell proliferation and metastasis","volume":"10","author":"Wu","year":"2017","journal-title":"OncoTargets Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e16870","article-title":"Long non-coding RNA AC245100.4 activates the PI3K\/AKT pathway to promote PCa cell proliferation by elevating PAR2","volume":"9","author":"Zhang","year":"2023","journal-title":"Heliyon"},{"key":"B34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3892\/ijmm.2021.4926","article-title":"Knockdown of lncRNA MIR4435\u22122HG and ST8SIA1 expression inhibits the proliferation, invasion and migration of prostate cancer cells in vitro and in vivo by blocking the activation of the FAK\/AKT\/B\u2212catenin signaling pathway","volume":"47","author":"Xing","year":"2021","journal-title":"Int J Mol Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13576","article-title":"Long non-coding RNA urothelial carcinoma associated 1 (UCA1) mediates radiation response in prostate cancer","volume":"8","author":"Fotouhi Ghiam","year":"2017","journal-title":"Oncotarget"},{"key":"B36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3892\/ol.2023.13724","article-title":"LncRNA SPRY4\u2212IT1 is upregulated and promotes the proliferation of prostate cancer cells under hypoxia in vitro","volume":"25","author":"Sang","year":"2023","journal-title":"Oncol Lett"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.895696","article-title":"Astragalus-scorpion drug pair inhibits the development of prostate cancer by regulating GDPD4-2\/PI3K\/AKT\/mTOR pathway and autophagy","volume":"13","author":"You","year":"2022","journal-title":"Front Pharmacol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"741109604","DOI":"10.1016\/j.abb.2023.109604","article-title":"FTO-stabilized miR-139-5p targets ZNF217 to suppress prostate cancer cell Malignancies by inactivating the PI3K\/akt\/mTOR signal pathway","volume":"741","author":"Azhati","year":"2023","journal-title":"Arch Biochem Biophys"},{"key":"B39","article-title":"MicroRNA-151 regulates the growth, chemosensitivity and metastasis of human prostate cancer cells by targeting PI3K\/AKT","volume":"25","author":"Chen","year":"2020","journal-title":"J BUON Off J Balk Union Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1949513","article-title":"Inhibition of microRNA miR-101-3p on prostate cancer progression by regulating cullin 4B (CUL4B) and PI3K\/AKT\/mTOR signaling pathways","volume":"12","author":"Gu","year":"2021","journal-title":"Bioengineered"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.10.037","article-title":"MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K\/AKT\/mTOR pathway in prostate cancer","volume":"96","author":"Xu","year":"2017","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.06.032","article-title":"RLIP76-dependent suppression of PI3K\/AKT\/bcl-2 pathway by miR-101 induces apoptosis in prostate cancer","volume":"463","author":"Yang","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.10165","article-title":"MiR-4638-5p inhibits castration resistance of prostate cancer through repressing kidins220 expression and PI3K\/AKT pathway activity","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"B44","doi-asserted-by":"publisher","first-page":"37160","DOI":"10.1186\/s13046-018-0813-4","article-title":"Downregulation of miR-133a-3p Promotes Prostate Cancer Bone Metastasis via Activating PI3K\/AKT Signaling","volume":"37","author":"Tang","year":"2018","journal-title":"J Exp Clin Cancer Res CR"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4447","article-title":"MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4\/PI3K\/akt\/P21 pathway","volume":"6","author":"Chang","year":"2015","journal-title":"Oncotarget"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14131","article-title":"Tumor-Suppressive microRNA-218 Inhibits Tumor Angiogenesis via Targeting the mTOR Component RICTOR in Prostate Cancer","volume":"8","author":"Guan","year":"2016","journal-title":"Oncotarget"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112128","article-title":"The miR-218\/GAB2 Axis Regulates Proliferation, Invasion and EMT via the PI3K\/AKT\/GSK-3\u03b2 Pathway in Prostate Cancer","volume":"394","author":"Tian","year":"2020","journal-title":"Exp Cell Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3892\/or.2016.4663","article-title":"miR-218 impedes IL-6-induced prostate cancer cell proliferation and invasion via suppression of LGR4 expression","volume":"35","author":"Li","year":"2016","journal-title":"Oncol Rep"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12031","article-title":"Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer","volume":"7","author":"Nip","year":"2016","journal-title":"Oncotarget"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/and.14016","article-title":"miR-21 inhibition reverses doxorubicin-resistance and inhibits PC3 human prostate cancer cells proliferation","volume":"53","author":"Zhao","year":"2021","journal-title":"Andrologia"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X2020e9695","article-title":"miR-182 modulates cell proliferation and invasion in prostate cancer via targeting ST6GALNAC5","volume":"54","author":"Bai","year":"2021","journal-title":"Braz J Med Biol Res Rev Bras Pesqui Medicas E Biol"},{"key":"B52","unstructured":"MicroRNA\u2212149 inhibits cancer cell Malignant phenotype by regulating Akt1 in C4\u22122 CRPC cell line"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142373","article-title":"Dual action of miR-125b as a tumor suppressor and oncomiR-22 promotes prostate cancer tumorigenesis","volume":"10","author":"Budd","year":"2015","journal-title":"PloS One"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075885","article-title":"Four microRNAs promote prostate cell proliferation with regulation of PTEN and its downstream signals in vitro","volume":"8","author":"Tian","year":"2013","journal-title":"PloS One"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/19932820.2021.1971837","article-title":"miR-92a promotes proliferation and inhibits apoptosis of prostate cancer cells through the PTEN\/akt signaling pathway","volume":"16","author":"Yanshen","year":"2021","journal-title":"Libyan J Med"},{"key":"B56","article-title":"Over-expression of miR-151a-3p inhibits proliferation and migration of PC-3 prostate cancer cells","volume":"34","author":"Zhang","year":"2018","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi Chin J Cell Mol Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3341","article-title":"miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2017.09.028","article-title":"Down-Regulation of miR-605 Promotes the Proliferation and Invasion of Prostate Cancer Cells by up-Regulating EN2","volume":"190","author":"Zhou","year":"2017","journal-title":"Life Sci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-18-0141","article-title":"AKT inhibition modulates H3K4 demethylase levels in PTEN-null prostate cancer","volume":"18","author":"Khan","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/cells11203285","article-title":"Apelin Promotes Prostate Cancer Metastasis by Downregulating TIMP2 via Increases in miR-106a-5p Expression","volume":"11","author":"Lin","year":"2022","journal-title":"Cells"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16755","article-title":"Involvement of miR-106b in tumorigenic actions of both prolactin and estradiol","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2016.08.043","article-title":"Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression","volume":"79","author":"Wan","year":"2016","journal-title":"Int J Biochem Cell Biol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9992","article-title":"Androgen-Induced miR-135a Acts as a Tumor Suppressor through Downregulating RBAK and MMP11, and Mediates Resistance to Androgen Deprivation Therapy","volume":"7","author":"Wan","year":"2016","journal-title":"Oncotarget"},{"key":"B64","doi-asserted-by":"publisher","first-page":"21173","DOI":"10.1186\/s12943-022-01630-9","article-title":"CircSMARCC1 Facilitates Tumor Progression by Disrupting the Crosstalk between Prostate Cancer Cells and Tumor-Associated Macrophages via miR-1322\/CCL20\/CCR6 Signaling","volume":"21","author":"Xie","year":"2022","journal-title":"Mol Cancer"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103432","article-title":"Circular RNA circMBOAT2 Promotes Prostate Cancer Progression via a miR-1271-5p\/mTOR Axis","volume":"12","author":"Shi","year":"2020","journal-title":"Aging"},{"key":"B66","doi-asserted-by":"publisher","first-page":"20207586521","DOI":"10.1155\/2020\/7586521","article-title":"Circular RNA cir-ITCH is a potential therapeutic target for the treatment of castration-resistant prostate cancer","volume":"2020","author":"Li","year":"2020","journal-title":"BioMed Res Int"},{"key":"B67","doi-asserted-by":"publisher","first-page":"76109780","DOI":"10.1016\/j.cellsig.2020.109780","article-title":"piR-001773 and piR-017184 promote prostate cancer progression by interacting with PCDH9","volume":"96","author":"Zhang","year":"2020","journal-title":"Cell Signal"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1186\/s12943-023-01766-2","article-title":"The function and mechanisms of action of circular RNAs in urologic cancer","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol Cancer"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumor microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B70","doi-asserted-by":"publisher","first-page":"18123","DOI":"10.1186\/s12943-019-1052-9","article-title":"The emerging role of the piRNA\/piwi complex in cancer","volume":"18","author":"Liu","year":"2019","journal-title":"Mol Cancer"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194947","article-title":"Extracellular matrix alterations in metastatic processes","volume":"20","author":"Paolillo","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.05.029","article-title":"Anoikis resistance and tumor metastasis","volume":"272","author":"Simpson","year":"2008","journal-title":"Cancer Lett"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2010.02.001","article-title":"Targeting anoikis resistance in prostate cancer metastasis","volume":"31","author":"Sakamoto","year":"2010","journal-title":"Mol Aspects Med"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-2990","article-title":"PI(3) king apart PTEN\u2019s role in cancer","volume":"16","author":"Zhang","year":"2010","journal-title":"Clin Cancer Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1186\/s40164-017-0077-2","article-title":"The role of cullin4B in human cancers","volume":"6","author":"Li","year":"2017","journal-title":"Exp Hematol Oncol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2011.03.055","article-title":"The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation","volume":"60","author":"De Nunzio","year":"2011","journal-title":"Eur Urol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/1476-4598-2-29","article-title":"The biology of the ets1 proto-oncogene","volume":"2","author":"Dittmer","year":"2003","journal-title":"Mol Cancer"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2015.09.010","article-title":"The role of the transcription factor ets1 in carcinoma","volume":"35","author":"Dittmer","year":"2015","journal-title":"Semin Cancer Biol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1158\/0008-5472.CAN-16-1656","article-title":"HER2 and EGFR overexpression support metastatic progression of prostate cancer to bone","volume":"77","author":"Day","year":"2017","journal-title":"Cancer Res"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2014.08.101","article-title":"Protocadherin 9 inhibits epithelial-mesenchymal transition and cell migration through activating GSK-3\u03b2 in hepatocellular carcinoma","volume":"452","author":"Zhu","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-015-9712-7","article-title":"Loss of PCDH9 is associated with the differentiation of tumor cells and metastasis and predicts poor survival in gastric cancer","volume":"32","author":"Chen","year":"2015","journal-title":"Clin Exp Metastasis"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.903554","article-title":"PCDH9 suppresses melanoma proliferation and cell migration","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"169103543","DOI":"10.1016\/j.critrevonc.2021.103543","article-title":"Obesity and prostate cancer: A narrative review","volume":"169","author":"Wilson","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2005.07.023","article-title":"Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade","volume":"36","author":"Liao","year":"2005","journal-title":"Hum Pathol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3892\/ol.2018.8613","article-title":"MALAT1: A long non-coding RNA highly associated with human cancers","volume":"16","author":"Zhao","year":"2018","journal-title":"Oncol Lett"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2017.06.004","article-title":"Cell cycle control by PTEN","volume":"429","author":"Brandmaier","year":"2017","journal-title":"J Mol Biol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-023-08251-5","article-title":"The role of hypoxia on prostate cancer progression and metastasis","volume":"50","author":"Mohamed","year":"2023","journal-title":"Mol Biol Rep"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3233\/SHTI230879","article-title":"IL-6 enhances the viability and invasion ability of prostate cancer cells","volume":"308","author":"Cheng","year":"2023","journal-title":"Stud Health Technol Inform"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2008.11.013","article-title":"Regression of prostate cancer xenografts by RLIP76 depletion","volume":"77","author":"Singhal","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019139","article-title":"MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1\u03b1 Expression","volume":"6","author":"Liu","year":"2011","journal-title":"PloS One"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.30344","article-title":"Molecular mechanism of VEGF and its role in pathological angiogenesis","volume":"123","author":"Ahmad","year":"2022","journal-title":"J Cell Biochem"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27740","article-title":"Cancer stem cells (CSCs) in cancer progression and therapy","volume":"234","author":"Najafi","year":"2019","journal-title":"J Cell Physiol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1166\/jbn.2021.3020","article-title":"Ultrasound-induced microbubble cavitation combined with miR-34a-loaded nanoparticles for the treatment of castration-resistant prostate cancer","volume":"17","author":"Wang","year":"2021","journal-title":"J Biomed Nanotechnol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188491","article-title":"Non-coding RNAs and potential therapeutic targeting in cancer","volume":"1875","author":"Toden","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-017-0553-x","article-title":"A randomized phase 2 study of a HSP27 targeting antisense, apatorsen with prednisone versus prednisone alone, in patients with metastatic castration resistant prostate cancer","volume":"36","author":"Yu","year":"2018","journal-title":"Invest New Drugs"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-021-00275-5","article-title":"rAAV-based and intraprostatically delivered miR-34a therapeutics for efficient inhibition of prostate cancer progression","volume":"29","author":"Ai","year":"2022","journal-title":"Gene Ther"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S254185","article-title":"CircRNA SMARCC1 sponges miR-140-3p to regulate cell progression in colorectal cancer","volume":"12","author":"Chen","year":"2020","journal-title":"Cancer Manage Res"},{"key":"B98","doi-asserted-by":"publisher","first-page":"27vi564","DOI":"10.1093\/annonc\/mdw435.20","article-title":"Genitourinary tumours, prostate final overall survival (OS) from the AFFINITY phase 3 trial of custirsen and cabazitaxel\/prednisone in men with previously treated metastatic castration-resistant prostate cancer (mCRPC)","volume":"27","author":"Fizazi","year":"2016","journal-title":"Ann Oncol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00219-z","article-title":"Noncoding RNA therapeutics \u2014 Challenges and potential solutions","volume":"20","author":"Winkle","year":"2021","journal-title":"Nat Rev Drug Discovery"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.chmed.2023.05.003","article-title":"Chinese herbal medicines for prostate cancer therapy: from experimental research to clinical practice","volume":"15","author":"Kong","year":"2023","journal-title":"Chin Herb Med"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw068","article-title":"A phase I dose-escalation study of apatorsen (OGX-427), an antisense inhibitor targeting heat shock protein 27 (Hsp27) , in patients with castration-resistant prostate cancer and other advanced cancers","volume":"27","author":"Chi","year":"2016","journal-title":"Ann Oncol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014254","article-title":"Meta-analysis of efficacy and safety of custirsen in patients with metastatic castration-resistant prostate cancer","volume":"98","author":"Zhang","year":"2019","journal-title":"Med\u00a0(Baltimore)"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.2810","article-title":"Designing a Gold Nanoparticle-Based Nanocarrier for microRNA Transfection into the Prostate and Breast Cancer Cells","volume":"16","author":"Ekin","year":"2014","journal-title":"J\u00a0Gene Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-022-01241-3","article-title":"Nanocarriers for cancer nano-immunotherapy","volume":"13","author":"Rana","year":"2023","journal-title":"Drug Deliv Transl Res"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004475","article-title":"Complementary traditional chinese medicine therapy improves survival in patients with metastatic prostate cancer","volume":"95","author":"Liu","year":"2016","journal-title":"Med (Baltimore)"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.41686","article-title":"Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K\/akt signaling pathways","volume":"16","author":"Lu","year":"2020","journal-title":"Int J Biol Sci"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-2355","article-title":"Micellar delivery of miR-34a modulator rubone and paclitaxel in resistant prostate cancer","volume":"77","author":"Wen","year":"2017","journal-title":"Cancer Res"},{"key":"B108","doi-asserted-by":"publisher","first-page":"228107932","DOI":"10.1016\/j.pharmthera.2021.107932","article-title":"Prostate cancer biomarkers: from diagnosis to prognosis and precision-guided therapeutics","volume":"228","author":"Adamaki","year":"2021","journal-title":"Pharmacol Ther"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.8b00650","article-title":"Re-engineering RNA molecules into therapeutic agents","volume":"52","author":"Egli","year":"2019","journal-title":"Acc Chem Res"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124507","article-title":"The PI3K-AKT-mTOR pathway and prostate cancer: at the crossroads of AR, MAPK, and WNT signaling","volume":"21","author":"Shorning","year":"2020","journal-title":"Int\u00a0J\u00a0Mol Sci"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-012-0285-1","article-title":"Custirsen (OGX-011): clusterin inhibitor in metastatic prostate cancer","volume":"15","author":"Al-Asaaed","year":"2013","journal-title":"Curr Oncol Rep"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat Rev Drug Discovery"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010385","article-title":"Safe nanoparticles: are we there yet? Int","volume":"22","author":"Najahi-Missaoui","year":"2020","journal-title":"J Mol Sci"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0051","article-title":"MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells","volume":"15","author":"Lee","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B115","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3892\/ijo.2011.1012","article-title":"miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer","volume":"39","author":"Tatarano","year":"2011","journal-title":"Int J Oncol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2009.02.002","article-title":"Change in Expression of miR-Let7c, miR-100, and miR-218 from High Grade Localized Prostate Cancer to Metastasis","volume":"29","author":"Leite","year":"2011","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00580-8","article-title":"Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): A multicentre, randomised, double-blind, phase 3 trial","volume":"398","author":"Sweeney","year":"2021","journal-title":"Lancet Lond Engl"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1525741\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T07:03:29Z","timestamp":1742281409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1525741\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,18]]},"references-count":117,"alternative-id":["10.3389\/fimmu.2025.1525741"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1525741","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,18]]},"article-number":"1525741"}}